Stan Fisher is a trial lawyer who focuses his practice primarily on intellectual property, FDA, and general commercial disputes. Stan has tried cases for Pfizer, Merck, Samsung, AstraZeneca, Bayer, Alcon, and Vornado Realty Trust. 

A substantial portion of Stan’s practice involves patent and licensing disputes. In addition to serving as trial and appeal counsel in federal and state courts and before arbitral tribunals, Stan frequently advises clients on patent office proceedings of strategic importance to their patents or products. Stan has also litigated a variety of disputes involving food and drug law, contracts and business torts, so-called “soft” intellectual property (trade secrets, trademarks, and copyrights), and antitrust law.

Stan is Immediate Past President of the Giles S. Rich American Inn of Court, the Intellectual Property Inn of Court in Washington, D.C. generally affiliated with the U.S. Court of Appeals for the Federal Circuit. He was named a "Super Lawyer" in 2016-2017 and a Washington, D.C. “Rising Star” for intellectual property in 2014  by Super Lawyers, a rating service affiliated with Reuters.

Stan received his B.S. in Molecular Biophysics & Biochemistry from Yale College in 1997 and his J.D. from The George Washington University Law School in 2004, where he graduated with Highest Honors and served as Editor-in-Chief of The George Washington Law Review. He joined Williams & Connolly in March 2006 after clerking for Judge Richard Linn at the U.S. Court of Appeals for the Federal Circuit. He is a current member of the firm's Hiring and Budget Committees.

Representative Experience

Though all cases vary and none is predictive, Stan’s experience includes:

  • Trial counsel to a major technology company in an international patent licensing arbitration before a three-member panel involving the price the company was required to pay to extend a patent license agreement covering products with billions of dollars in revenue.
  • Trial counsel for AstraZeneca in the first “pay-for-delay” antitrust case tried following the Supreme Court’s decision FTC v. Actavis.  The case was at the intersection of antitrust, patent, and FDA law.  The jury returned a defense verdict.  The U.S. Court of Appeals for the First Circuit affirmed the jury’s verdict in favor of AstraZeneca, finding that the plaintiffs had not shown that they had suffered an antitrust injury that entitled them to damages.
  • Trial counsel to Pfizer, Inc. in a number of Hatch-Waxman patent cases against different generic manufacturers.  These include related cases involving the drug, Tygacil®, a broad spectrum antibiotic with $150 million in annual U.S. sales.  Pfizer subsidiary Wyeth prevailed on all claims against Apotex in one of the first inter partes review pharmaceutical patent cases decided by the PTAB and the Court of Appeals for the Federal Circuit.
  • Counsel for Endo Pharmaceuticals in antitrust litigation in the Northern District of California.  The case concerned allegations that a patent settlement between Endo and Watson Pharmaceuticals concerning Endo’s pain patch, Lidoderm, violated the antitrust laws.  
  • Trial counsel in additional Hatch-Waxman work for Pfizer including defending against Mylan’s challenge to the patents on Pfizer’s cancer drug, Sutent® which sells over $1 Billion per year.  The District Court ruled in Pfizer’s favor.  The Court of Appeals for the Federal Circuit affirmed the decision on appeal.
  • Counsel for Bayer in an Administrative Procedure Act challenge to FDA’s approval of generic versions of Bayer’s veterinary antibiotic drug Baytril®. 
  • Counsel for global diagnostics company in patent litigation involving diagnostic kits for the detection of HIV virus in blood products in the both the PTAB and federal district court.
  • Counsel for a global pharmaceutical company in two significant antitrust cases involving allegations that the company delayed development of generic versions of two drugs.
  • Counsel to several pharmaceutical companies in “brand v. brand” pharmaceutical patent litigation.
  • Counsel to Alice Corporation in the landmark CLS Bank International v. Alice Corporation matter before the district court and Federal Circuit.
  • Counsel to technology company in a patent infringement case concerning smartphones with cameras.
  • Counsel to media company in a copyright infringement and breach of contract case against a direct-broadcast satellite service provider and its affiliated entities.
  • Counsel in various licensing disputes. 
  • Counsel to a venture-backed medical device company in confidential arbitration over a dispute involving the interpretation of a Warrant Agreement.




Selected to Super Lawyers, 2016-2017

Selected to Washington, D.C. “Rising Stars” list, Super Lawyers, 2014


back to top